1. Velligan DI, Lam F, Ereshefsky L, Miller AL. Psychopharmacology: perspectives on medication adherence and atypical antipsychotic medications. Psychiatr Serv 2003;54:665-7.

2. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Patient adherence in the treatment of depression. Br J Psychiatr 2002;180:104-9.

3. Demyttenaere K. Compliance during treatment with antidepressants. J Affect Disord 1997;8:27-39.

4. Klein DN, Schwartz JE, Santiago NJ, Vivian D, Vocisano C, Castonguay LG, Arnow B, Blalock JA, Manber R, Markowitz JC, Riso LP, Rothbaum B, McCullough JP, Thase ME, Borian FE, Miller IW, Keller MB. Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics. J Consul Clin Psychol 2003;71:997.

5. McCabe R, Bullenkamp J, Hansson L, Lauber C, Martinez-Leal R. , Rössler W, Salize HJ, Svensson B, Torres-Gonzalez F, van den Brink R, Wiersma D, Priebe S. The therapeutic relationship and adherence to antipsychotic medication in schizophrenia. PLoS One 2012;7:e36080.

6. Bosch P, Waberg J, van den Noort M, Staudte H, Lim S, Egger J. Symptom severity, quality of sleep, and treatment adherence among patients suffering from schizophrenia and depression. Neuroimmunol Neuroinflammation 2016;3:109-16.

7. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatr 2002;63:892-909.

8. Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatr Res 2010;176:109-13.

Neuroimmunology and Neuroinflammation
ISSN 2349-6142 (Online) 2347-8659 (Print)


All published articles are preserved here permanently:


All published articles are preserved here permanently: